NCT02717156
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02717156
Title Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
LAC+USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
USC Norris Oncology/Hematology - Newport Beach Newport Beach California 92663 United States Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Kansas Cancer Center Kansas City Kansas 66205 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Levine Cancer Institute-Carolinas Medical Center Charlotte North Carolina 28277 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field